On June 8th, Gelunhui reported that New Ruipeng Pet Medical Group (RPET.US), an innovative and entrepreneurial enterprise whose main business is chain pet medical care, withdrew its IPO plan in the United States. The company initially filed an application in January 2023 and planned to raise $100 million. New Ruipeng stated that the decision to voluntarily withdraw the IPO application materials was the result of comprehensive and prudent consideration of the market environment and the company's overall development strategy. Currently, the company's operations continue to improve. Next, the company will continue to closely monitor the global capital market trends and select a more suitable timing to resume the listing process.
新瑞鹏主动撤回赴美IPO申请：挑选更加合适的时机重启上市进程
Xinruipeng voluntarily withdrew its application for IPO in the United States and will restart the listing process at a more appropriate time.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.